New York College of Podiatric Medicine Receives Donation of PathoLase, Inc.'s New PinPointe(TM) FootLaser(TM) and Will Teach Its Use in Conjunction with Clinical Research Study Evaluating It for Treatment of Toenail Fungus

NEW YORK--(BUSINESS WIRE)--The New York College of Podiatric Medicine (NYCPM), the nation’s first and largest college of podiatric medicine, today announced that it has received a donation from PathoLase, Inc., of the company’s patented new PinPointe™ FootLaser™ for the treatment of nail fungus (Onychomycosis), and will be teaching the College’s students to use the new technology in conjunction with a clinical research study to be conducted at the College’s clinical affiliate, Foot Clinics of New York.